Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  5, Issue 1, January 2018, Pages 35-39
 

Original Article

Low Dose Dexamethasone Reduces Spinal Buprenorphine Associated Nausea and Vomiting

Purushothaman Athul M.1, Pujari Vinayak S.2

1Senior Resident 2Associate Professor, Department of Anaesthesiology, MS Ramaiah Medical College & Hospitals, New BEL Road, MSR Nagar, Bangalore-560054, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.5118.6

Abstract

Background: Intrathecal Buprenorphine is an adjuvant to spinal anaesthesia offers the advantage of providing good analgesia, but is associated postoperative nausea and vomiting. Dexamethasone is a potent steroid and has good antiemetic effect. The aim of this randomized controlled trial was to compare the antiemetic efficacy of dexamethasone 4 and 8mg. Methods: 180 patients of either sex undergoing elective lower extremities and infra umbilical surgeries were included in the study. The patients in group D0, D4 and D8 received 5ml normal saline, 4 mg and 8mg dexamethasone respectively before spinal anaesthesia. Spinal anaesthesia was established with a single bolus of 0.5% hyperbaric bupivacaine 15 mg and buprenorphine 60mcg. The primary end point of this study was the total nausea and vomiting rate for 8 hours post spinal anaesthesia. The secondary end points were the incidence of nausea, vomiting and the occurrence of adverse events like pruritis. Statistical Analysis: The incidence of nausea, vomiting and pruritus was analyzed using a series of 3×2 2 tests. Results: Demographic profile was similar between the groups. The incidence of nausea was 16% in group D0 and was 5% in the groupD4 and D8. The incidence of vomiting was 5%, 3.3%and 1.7% in the D0, D4 and D8 groups respectively. The incidence of nausea and vomiting was not very different in the D4 and D8 groups. Conclusions: Both doses of prophylactic dexamethasone 4/8 mg significantly reduces the nausea and vomiting associated with intrathecal Buprenorphine. A dose of 4mg of dexamethasone is as efficacious as 8mg.


Keywords : Buprenorphine; Dexamethasone; Intrathecal Opiates; Nausea and Vomiting. 
Corresponding Author : Vinayak S. Pujari, Associate Professor, Department of Anaesthesiology, MS Ramaiah Medical College & Hospitals, New BEL Road, MSR Nagar, Bangalore-560054, India.